Coldstream Capital Management Inc Neurocrine Biosciences Inc Transaction History
Coldstream Capital Management Inc
- $5.98 Billion
- Q2 2025
A detailed history of Coldstream Capital Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 3,775 shares of NBIX stock, worth $526,348. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,775
Previous 3,650
3.42%
Holding current value
$526,348
Previous $403,000
17.62%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.98 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.37 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$776 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$623 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$430 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...